Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

After successfully obtaining a drug licence, what routine inspections will the Department of Health conduct, and how often?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q25 · Category A: Pharmaceutical Licensing System and Regulatory Framework (Q1-Q50)
Obtaining a pharmaceutical licence is the beginning, not the end, of compliant business operations. The Drug Office, Department of Health conducts routine inspections of all licensed premises to ensure that licence holders continue to comply with relevant laws and codes of practice. Inspection frequency depends on the licence type and risk level. Higher-risk licence holders, such as medicine manufacturers and wholesalers, are generally inspected more frequently; for example, a comprehensive GDP or GMP re-inspection may take place every 1 to 2 years. Routine inspections of retail pharmacies and dispensaries may be less frequent, but the Department of Health also conducts unannounced ‘mystery shopper’-style inspections to check for breaches such as the illegal sale of prescription medicines. During inspections, officers will examine your premises, records (such as purchasing, sales and temperature records), staff qualifications and operating procedures. After the inspection, you will receive a report identifying any deficiencies and requiring you to correct them within a specified period.

📘 Regulatory basis

The Pharmacy and Poisons Ordinance empowers inspectors of the Department of Health to enter, inspect and take samples. Inspection procedures and standards are based on the relevant codes of practice (such as GDP and GSP).

📗 Drew Tang's recommendations

Do not treat an inspection as an “exam”; view it instead as a free “health check” of your Quality Management System. We recommend that clients establish an internal self-inspection mechanism and regularly simulate official inspections to identify and resolve issues proactively. This will help you face an actual inspection with confidence.

📕 Risk notice

Any serious breach found during an inspection may trigger disciplinary proceedings, resulting in a fine or suspension or revocation of the licence. Delaying or taking a perfunctory approach to addressing issues identified during an inspection will only make the consequences worse.

Back to Category A: Licence System and Regulatory Basics (Q1-Q50) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗